No Dose Change Recommended
With a TSH of 1.18 mIU/L (normal) and mildly elevated free T4 of 1.2 ng/dL, you should maintain the current levothyroxine 100 mcg dose without adjustment. 1
Rationale Based on Guidelines
The AACE/ATA guidelines explicitly state that TSH is the most reliable therapeutic endpoint for primary hypothyroidism 1. When TSH is within the normal range, free T4 will also be in the normal range, and confirmatory T4 levels do not have sufficient specificity to serve as therapeutic endpoints by themselves 1.
Why Elevated Free T4 is Expected and Acceptable
Patients on levothyroxine replacement characteristically have higher free T4 levels than untreated euthyroid individuals, even when TSH is normal 1. The guidelines note that:
- Mean free T4 values in L-thyroxine-treated patients tend to be higher than mean values in untreated controls 1
- This is a recognized physiological pattern of replacement therapy 2, 3
- Recent research (2025-2026) confirms levothyroxine-treated patients show significantly higher median free T4 levels (17.9 pmol/L) compared to untreated patients (16.2 pmol/L), despite similar TSH levels 3, 4
The TSH-Guided Approach
Your patient's TSH of 1.18 mIU/L falls well within the normal reference range (upper limit 4.12 mIU/L) and is close to the population mean/median of approximately 1.5 mIU/L 1. This indicates:
- Adequate replacement has been achieved 1
- The slightly elevated free T4 is maintaining appropriate thyroid hormone availability
- No adjustment is warranted based on TSH alone
Important Caveats
When to Consider Dose Reduction
You should only reduce the dose if:
- Clinical signs of overtreatment emerge: tachycardia, palpitations, tremor, anxiety, weight loss, heat intolerance 1
- TSH becomes suppressed (< 0.4 mIU/L), which carries cardiovascular risks (atrial fibrillation, especially in elderly) and skeletal risks (accelerated bone loss in postmenopausal women) 1
- Patient is elderly or has underlying cardiovascular disease and develops cardiac symptoms 1
Monitoring Schedule
Since adequate replacement has been determined:
- Recheck TSH in 6-12 months 1
- Recheck sooner (4-8 weeks) only if: medications affecting absorption/metabolism are added/discontinued, significant weight change occurs, or clinical status changes 1
Common Pitfall to Avoid
Do not chase the mildly elevated free T4 by reducing levothyroxine dose when TSH is normal. This is the single most common error in thyroid management. The elevated free T4 is necessary to maintain adequate T3 levels through peripheral conversion 2, 3. Reducing the dose based on free T4 alone will likely result in:
- Rising TSH into the hypothyroid range
- Inadequate thyroid hormone replacement
- Return of hypothyroid symptoms
- Unnecessary dose adjustments over subsequent months
The free T4/free T3 ratio is inherently different in treated versus untreated individuals—this is expected physiology, not overtreatment 2, 3, 4.